BioCentury
ARTICLE | Company News

Catalent, Roche deal

February 1, 2016 8:00 AM UTC

Catalent granted Roche non-exclusive access to the SMARTag platform and options to develop and commercialize resulting molecules against undisclosed targets. Catalent will receive $1 million up front ...